The prognostic significance of multiple station N2 in patients with surgically resected stage IIIA N2 non-small cell lung cancer

被引:15
|
作者
Lee, Jin Gu [1 ]
Lee, Chang Young [1 ]
Park, In Kyu [1 ]
Kim, Dae Joon [1 ]
Cho, Sang Ho [1 ]
Kim, Kil Dong [2 ]
Chung, Kyung Young [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 120752, South Korea
[2] Eulji Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Taejon, South Korea
关键词
lung neoplasms; lymph node; neoplasm metastasis; prognosis;
D O I
10.3346/jkms.2008.23.4.604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mediastinal (N2) lymph node involvement is heterogenous with huge variation in the extent and grouped together under stage IIIA. However, they showed a different survival even in the same stage. We tried to determine the prognostic implication of the multiple station N2 lymph node metastasis in stage IIIA N2 non-small cell lung cancer (NSCLC). The survival of stage IIIA N2 was analyzed according to the number of N2 station and their survival was compared with that of stage IIIB. In stage IIIA N2 NSCLC, multivariate analysis indicated that multiple station N2 was one of the independent prognostic factors for poor survival. The 5-yr survival of multiple station N2 IIIA (20.4%) was lower than that of single station N2 IIIA (33.8%) significantly (p=0.016). but when it was compared with that of stage IIIB (15.5%), there was no difference. Therefore, we suggest that multiple station N2 should be considered similar to stage IIIB disease with regard to predicting survival and accordingly should receive a new position in the TNM staging system.
引用
收藏
页码:604 / 608
页数:5
相关论文
共 50 条
  • [21] Management of stage IIIA (N2) non-small cell lung cancer: A transatlantic perspective
    Rocco, Gaetano
    Nason, Katie
    Brunelli, Alex
    Varela, Gonzalo
    Waddell, Thomas
    Jones, David R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (05): : 1235 - 1238
  • [22] Survival impact of unexpected N2 in stage IIIB/N2 non-small cell lung cancer patients
    Erdogu, Volkan
    Citak, Necati
    Sezen, Celal Bugra
    Kizir, Dilekhan
    Tanrikulu, Gamze
    Dogru, Mustafa Vedat
    Seyrek, Yunus
    Cansever, Levent
    Saydam, Ozkan
    Metin, Muzaffer
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2023, 31 (03): : 238 - 243
  • [23] Risk Prediction of Multiple-station N2 Metastasis in Patients with Clinical Single-station N2 Non-small Cell Lung Cancer
    Kim, J. Y.
    Yun, J. K.
    Lee, G. D.
    Choi, S.
    Kim, H. R.
    Kim, Y-H.
    Kim, D. K.
    Park, S. -I.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S293 - S294
  • [24] The Management of Patients With Stage IIIA Non-Small Cell Lung Cancer With N2 Mediastinal Node Involvement
    Martins, Renato G.
    D'Amico, Thomas A.
    Loo, Billy W., Jr.
    Pinder-Schenck, Mary
    Borghaei, Hossein
    Chaft, Jamie E.
    Ganti, Apar Kishor P.
    Kong, Feng-Ming
    Kris, Mark G.
    Lennes, Inga T.
    Wood, Douglas E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (05): : 599 - 613
  • [25] The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy
    Yang, Hui
    Wang, Kunlun
    Li, Shenglei
    Li, Yan
    Yuan, Ling
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [26] Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer
    Cho, Hyun Jin
    Kim, Sung Ryong
    Kim, Hyeong Ryul
    Han, Jin-Ok
    Kim, Yong-Hee
    Kim, Dong Kwan
    Park, Seung-Il
    ANNALS OF THORACIC SURGERY, 2014, 97 (06): : 1920 - 1925
  • [27] Trimodal therapy and surgical approaches in stage IIIA/N2 non-small cell lung cancer
    Hu, Pin-Ching
    Huang, Jing-Yang
    Cheng, Ya-Fu
    Cheng, Ching-Yuan
    Huang, Chang-Lun
    Hung, Wei-Heng
    Wang, Bing-Yen
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Prognostic Factors in Patients with Pathological and N2 Non-Small Cell Lung Cancer
    Saito, Makoto
    Kato, Harubumi
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 14 (01) : 1 - 2
  • [29] Brain metastases in patients with stage N2 non-small cell lung cancer
    Lowrie, C.
    McCully, E.
    Ansel, S.
    McLoone, P.
    Mohammed, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S69 - S69
  • [30] Clinical significance of 18F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer:: A retrospective study
    Na, Im Il
    Cheon, Gi Jeong
    Choe, Du Hwan
    Byun, Byung Hyun
    Kang, Hye Jin
    Koh, Jae Soo
    Park, Jong Ho
    Baek, Hee Jong
    Ryoo, Baek-Yeol
    Lee, Jae Cheol
    Yang, Sung Hyun
    LUNG CANCER, 2008, 60 (01) : 69 - 74